WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Anticonvulsant-CMAP-v3.2, Seizure type has_reference_values Partial seizure, Potential exacerbation of pre-existing seizures summarized_by Seizure occurrence, Clinical Global Impression (CGI) is_documented_by Reporting entity, FDA Efficacy Endpoints for Anticonvulsant Therapies has_components Secondary efficacy endpoint, Repeated concepts/instances (e.g. Stroke, Death) are denoted by dotted outline, Primary efficacy endpoints (e.g. Seizure frequency) are denoted by bold font, Therapeutic Efficacy Point has Observation or Assessment, Seizure type has_reference_values Generalized seizure, Primary efficacy endpoint documents Seizure frequency, Total number of episodes of flurries occurs_during During evaluation period, CRF: Seizure record has_pertinent_information Seizure occurrence, FDA Efficacy Endpoints for Anticonvulsant Therapies has_components Primary efficacy endpoint, Partial seizure refers_to Partial seizure subtype, Concepts (e.g. Subgroup, NCB) are denoted by solid round-edged rectangle, Concepts which may be removed (for simplicity) are denoted by Gray shading, Generalized seizure subtype summarized_by Count of total number of seizures, Generalized seizure refers_to Generalized seizure subtype, Seizure frequency is_derived_from CRF: Seizure record, Development of new seizure types summarized_by Seizure occurrence, Seizure occurrence occurs_during During evaluation period